These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 15990699)

  • 1. Circulating transforming growth factor beta-1: a partial molecular explanation for associations between hypertension, diabetes, obesity, smoking and human disease involving fibrosis.
    Peterson MC
    Med Sci Monit; 2005 Jul; 11(7):RA229-32. PubMed ID: 15990699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A word on the possible role of the circulating transforming growth factor beta-1 in hypertension, diabetes, obesity, smoking and human disease involving fibrosis.
    Chatterjee S; Van Marck E
    Med Sci Monit; 2005 Sep; 11(9):LE10-11. PubMed ID: 16127368
    [No Abstract]   [Full Text] [Related]  

  • 3. Elevated circulating transforming growth factor beta-1 may explain poorer renal survival in type II diabetics with chronic hepatitis C.
    Peterson MC
    Med Sci Monit; 2007 May; 13(5):RA81-5. PubMed ID: 17476201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracellular matrix remodeling in the heart of the homocysteinemic obese rabbit.
    Carroll JF; Tyagi SC
    Am J Hypertens; 2005 May; 18(5 Pt 1):692-8. PubMed ID: 15882553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progression of chronic renal disease.
    Klahr S; Morrissey J
    Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S3-7. PubMed ID: 12612942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TGF-beta signaling in vascular fibrosis.
    Ruiz-Ortega M; Rodríguez-Vita J; Sanchez-Lopez E; Carvajal G; Egido J
    Cardiovasc Res; 2007 May; 74(2):196-206. PubMed ID: 17376414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BMP7 signaling in renal development and disease.
    Patel SR; Dressler GR
    Trends Mol Med; 2005 Nov; 11(11):512-8. PubMed ID: 16216558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The fibrosis and atrial fibrillation: is the transforming growth factor-beta 1 a candidate etiology of atrial fibrillation.
    Li X; Ma C; Dong J; Liu X; Long D; Tian Y; Yu R
    Med Hypotheses; 2008; 70(2):317-9. PubMed ID: 17689021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming growth factor-beta: a key mediator of fibrosis.
    Mauviel A
    Methods Mol Med; 2005; 117():69-80. PubMed ID: 16118446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypertension-mediated albuminuria is associated with reduced lysosomal activity in the kidney and the heart.
    Hilliard LM; Russo LM; Comper WD
    Am J Nephrol; 2009; 29(5):454-64. PubMed ID: 19023196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrotic response to angiotensin II is blunted in the kidney, but not in the heart, in insulin-sensitive long-lived transgenic dwarf rats.
    Sato O; Ashizawa N; Ohtsuru A; Imanishi R; Kawano H; Seto S; Yamashita S; Shimokawa I; Yano K
    Int J Mol Med; 2007 Jan; 19(1):23-7. PubMed ID: 17143544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. cDNA microarray analysis of adaptive changes after renal ablation in a sclerosis-resistant mouse strain.
    Rumberger B; Vonend O; Kreutz C; Wilpert J; Donauer J; Amann K; Rohrbach R; Timmer J; Walz G; Gerke P
    Kidney Blood Press Res; 2007; 30(6):377-87. PubMed ID: 17890868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma transforming growth factor beta1 as a biochemical marker to predict the persistence of atrial fibrillation after the surgical maze procedure.
    On YK; Jeon ES; Lee SY; Shin DH; Choi JO; Sung J; Kim JS; Sung K; Park P
    J Thorac Cardiovasc Surg; 2009 Jun; 137(6):1515-20. PubMed ID: 19464473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safflower extract: a novel renal fibrosis antagonist that functions by suppressing autocrine TGF-beta.
    Yang YL; Chang SY; Teng HC; Liu YS; Lee TC; Chuang LY; Guh JY; Chang FR; Liao TN; Huang JS; Yeh JH; Chang WT; Hung MY; Wang CJ; Chiang TA; Hung CY; Hung TJ
    J Cell Biochem; 2008 Jun; 104(3):908-19. PubMed ID: 18189272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Connective tissue growth factor and cardiac fibrosis.
    Daniels A; van Bilsen M; Goldschmeding R; van der Vusse GJ; van Nieuwenhoven FA
    Acta Physiol (Oxf); 2009 Mar; 195(3):321-38. PubMed ID: 19040711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TGF-beta in renal injury and disease.
    Böttinger EP
    Semin Nephrol; 2007 May; 27(3):309-20. PubMed ID: 17533008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding the role of transforming growth factor-beta signalling in the heart: overview of studies using genetic mouse models.
    Xiao H; Zhang YY
    Clin Exp Pharmacol Physiol; 2008 Mar; 35(3):335-41. PubMed ID: 18290874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship of transforming growth factor-beta(1) with tumour necrosis factor-alpha and endothelial activation in patients with stable renal transplantation.
    Palermo A; Mulè G; Vadalà A; Vaccaro F; Guarneri M; Arsena R; Briolotta C; Cerasola G; Cottone S
    Nephrology (Carlton); 2008 Apr; 13(2):164-70. PubMed ID: 18275506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antagonism of transforming growth factor-Beta signaling inhibits fibrosis-related genes.
    Liu XJ; Ruan CM; Gong XF; Li XZ; Wang HL; Wang MW; Yin JQ
    Biotechnol Lett; 2005 Oct; 27(20):1609-15. PubMed ID: 16245182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted disruption of Smad4 in cardiomyocytes results in cardiac hypertrophy and heart failure.
    Wang J; Xu N; Feng X; Hou N; Zhang J; Cheng X; Chen Y; Zhang Y; Yang X
    Circ Res; 2005 Oct; 97(8):821-8. PubMed ID: 16151019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.